The Vira Platform: A Contextually Triggered Just-in-Time Adaptive Intervention for Opioid Use Disorder
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Medication for Opioid Use Disorder Retention
研究概览
简要总结
Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Current Opioid Use Disorder diagnosis
- •Prescribed buprenorphine or methadone
- •Initiated or reinitiated buprenorphine or methadone treatment recently
- •Access to personal smartphone
排除标准
- •Not fluent in English
- •Limited mental capacity or inability to provided informed consent
研究组 & 干预措施
Vira Path
干预措施: Treatment-As-Usual (Behavioral)
Treatment-as-Usual
干预措施: Treatment-As-Usual (Behavioral)
Vira Path
干预措施: Vira Platform (Behavioral)
结局指标
主要结局
Medication for Opioid Use Disorder Retention
时间窗: Baseline & 3-Month Follow-up
Retention on buprenorphine or methadone treatment will be verified through medical record chart review.
Substance Use Disorder Treatment Engagement
时间窗: Baseline & 3-Month Follow-up
Addiction treatment records as assessed through medical records will be assessed for participation in addiction treatment services (e.g., 'detox', inpatient services, outpatient therapy).
次要结局
- Opioid Use assessed with the Timeline Follow-back(Baseline & 3-Month Follow-up)
- Anhedonia assessed with the Snaith-Hamilton Pleasure Scale(Baseline & 3-Month Follow-up)
- Sleep Deficiency assessed with the Insomnia Severity Index (ISI)(Baseline & 3-Month Follow-up)
- Negative Affect assessed with the Positive Affect and Negative Affect Schedule-Expanded Form(Baseline & 3-Month Follow-up)
- Perceived Quality of Life Measured with the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form(Baseline & 3-Month Follow-up)
- Wellbeing measured by the World Health Organization-Five Well-Being Index(Baseline & 3-Month Follow-up)
- Perceived Social Support assessed with the Multidimensional Scale of Perceived Social Support(Baseline & 3-Month Follow-up)
- Participant Safety(Baseline & 3-Month Follow-up)
- Opioid Craving measured with the Opioid Craving Scale(Baseline & 3-Month Follow-up)